MRK: Merck & Company Inc. (new) Stocks News on June 1, 2025

KEYTRUDA® (pembrolizumab) Plus Trodelvy® (sacituzumab govitecan-hziy) Reduced Risk of Disease Progression or Death by 35% Versus KEYTRUDA Plus Chemotherapy in First-Line PD-L1+ Metastatic Triple-Negative Breast Cancer (TNBC)

MRK

Business Wire

15 hours ago

KEYTRUDA® (pembrolizumab) Plus Trodelvy® (sacituzumab govitecan-hziy) Reduced Risk of Disease Progression or Death by 35% Versus KEYTRUDA Plus Chemotherapy in First-Line PD-L1+ Metastatic Triple-Negative Breast Cancer (TNBC)

ASCO25: MSD’s ADC candidate achieves 56.3% ORR in lymphoma trial

MRK

Clinical Trials Arena

a day ago

ASCO25: MSD’s ADC candidate achieves 56.3% ORR in lymphoma trial

MRK

Investor's Business Daily

2 days ago

Summit Therapeutics, A Top 1% Biotech, Plummets On A High-Profile Failure

Merck Announces MK-1084, an Investigational KRAS G12C Inhibitor, Shows Antitumor Activity in Phase 1 Trial of Patients With Advanced Colorectal Cancer and Non-Small Cell Lung Cancer Whose Tumors Harbor KRAS G12C Mutations

MRK

Business Wire

2 days ago

Merck Announces MK-1084, an Investigational KRAS G12C Inhibitor, Shows Antitumor Activity in Phase 1 Trial of Patients With Advanced Colorectal Cancer and Non-Small Cell Lung Cancer Whose Tumors Harbor KRAS G12C Mutations

$Merck’s Investigational Zilovertamab Vedotin at 1.75 mg/kg Dose Plus Standard of Care Showed Promising Antitumor Activity, Including Complete Response Rate, in Patients With Relapsed/Refractory DLBCL in Phase 2 Portion of waveLINE-003 Trial$

MRK

Business Wire

2 days ago

Merck’s Investigational Zilovertamab Vedotin at 1.75 mg/kg Dose Plus Standard of Care Showed Promising Antitumor Activity, Including Complete Response Rate, in Patients With Relapsed/Refractory DLBCL in Phase 2 Portion of waveLINE-003 Trial

2 Cash-Producing Stocks for Long-Term Investors and 1 to Steer Clear Of

MRK

StockStory

2 days ago

2 Cash-Producing Stocks for Long-Term Investors and 1 to Steer Clear Of

Merck KGaA (MKGAF) Files for Global Approval of Pimicotinib After Positive Phase III TGCT Results

MRK

Insider Monkey

2 days ago

Merck KGaA (MKGAF) Files for Global Approval of Pimicotinib After Positive Phase III TGCT Results

Merck & Co., Inc. (MRK) Is a Trending Stock: Facts to Know Before Betting on It

MRK

Zacks

3 days ago

Merck & Co., Inc. (MRK) Is a Trending Stock: Facts to Know Before Betting on It

MRK

MT Newswires

3 days ago

Merck Withdraws Biologics License Application for Patritumab Deruxtecan

Moderna suffers a $750 million loss from NIH funding cut

MRK

Yahoo Finance

3 days ago

Moderna suffers a $750 million loss from NIH funding cut

Patritumab Deruxtecan Biologics License Application for Patients with Previously Treated Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer Voluntarily Withdrawn

MRK

Business Wire

3 days ago

Patritumab Deruxtecan Biologics License Application for Patients with Previously Treated Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer Voluntarily Withdrawn

Merck (NYSE:MRK) Declares US$0.81 Dividend for Q3 2025 Payout

MRK

Simply Wall St.

3 days ago

Merck (NYSE:MRK) Declares US$0.81 Dividend for Q3 2025 Payout

Merck Announces Third-Quarter 2025 Dividend

MRK

Business Wire

4 days ago

Merck Announces Third-Quarter 2025 Dividend

Merus Skyrockets On 'Unprecedented' Cancer Results, Slamming Bicara Therapeutics

MRK

Investor's Business Daily

9 days ago

Merus Skyrockets On 'Unprecedented' Cancer Results, Slamming Bicara Therapeutics

MRK

StockStory

9 days ago

3 Dow Jones Stocks on Our Watchlist

Merck to Participate in the Bernstein 41st Annual Strategic Decisions Conference

MRK

Business Wire

10 days ago

Merck to Participate in the Bernstein 41st Annual Strategic Decisions Conference

Merck & Co., Inc. (MRK): A Bull Case Theory

MRK

Insider Monkey

10 days ago

Merck & Co., Inc. (MRK): A Bull Case Theory

Merck (NYSE:MRK) Collaborates With Antengene For Promising Cancer Therapy Evaluation

MRK

Simply Wall St.

11 days ago

Merck (NYSE:MRK) Collaborates With Antengene For Promising Cancer Therapy Evaluation

MRK

MT Newswires

12 days ago

Berenberg Adjusts Price Target on Merck & Co. to $100 From $115, Maintains Buy Rating

PFE vs. MRK: Which Oncology Drug Giant is a Better Buy Now?

MRK

Zacks

13 days ago

PFE vs. MRK: Which Oncology Drug Giant is a Better Buy Now?

IDeate-Esophageal01 Phase 3 Trial of Ifinatamab Deruxtecan Initiated in Certain Patients with Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma

MRK

Business Wire

13 days ago

IDeate-Esophageal01 Phase 3 Trial of Ifinatamab Deruxtecan Initiated in Certain Patients with Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma

MRK

The Wall Street Journal

13 days ago

The Top Corporate Board Directors

Merck to Present New Clinical and Outcomes Research Data at The American Thoracic Society’s (ATS) 2025 International Conference Demonstrating Commitment to Advancing Research in Pulmonary Arterial Hypertension

MRK

Business Wire

16 days ago

Merck to Present New Clinical and Outcomes Research Data at The American Thoracic Society’s (ATS) 2025 International Conference Demonstrating Commitment to Advancing Research in Pulmonary Arterial Hypertension

FDA awards cancer drug approvals to AbbVie and MSD

MRK

Pharmaceutical Technology

16 days ago

FDA awards cancer drug approvals to AbbVie and MSD

FDA approves Merck’s belzutifan for pheochromocytoma or paraganglioma

MRK

TipRanks

16 days ago

FDA approves Merck’s belzutifan for pheochromocytoma or paraganglioma

Jefferies not seeing significant impact to Merck, Bristol from draft guidance

MRK

TipRanks

16 days ago

Jefferies not seeing significant impact to Merck, Bristol from draft guidance

Merck Announces Phase 3 KEYNOTE-B96 Trial Met Primary Endpoint of Progression-Free Survival (PFS) in Patients With Platinum-Resistant Recurrent Ovarian Cancer Whose Tumors Expressed PD-L1 and in All Comers

MRK

Business Wire

17 days ago

Merck Announces Phase 3 KEYNOTE-B96 Trial Met Primary Endpoint of Progression-Free Survival (PFS) in Patients With Platinum-Resistant Recurrent Ovarian Cancer Whose Tumors Expressed PD-L1 and in All Comers

MRK

Zacks

17 days ago

The Zacks Analyst Blog Highlights Oracle, IBM, Merck and Earth Science Tech

MRK

Morningstar Research

17 days ago

Analyst Report: Merck & Co., Inc.

Top Analyst Reports for Oracle, IBM & Merck

MRK

Zacks

17 days ago

Top Analyst Reports for Oracle, IBM & Merck

FDA Approves Merck’s WELIREG® (belzutifan) for the Treatment of Adults and Pediatric Patients 12 Years and Older With Locally Advanced, Unresectable, or Metastatic Pheochromocytoma or Paraganglioma (PPGL)

MRK

Business Wire

17 days ago

FDA Approves Merck’s WELIREG® (belzutifan) for the Treatment of Adults and Pediatric Patients 12 Years and Older With Locally Advanced, Unresectable, or Metastatic Pheochromocytoma or Paraganglioma (PPGL)

FDA Approves Merck's Kidney Cancer Drug For Rare Type Of Neuroendocrine Tumors

MRK

Benzinga

17 days ago

FDA Approves Merck's Kidney Cancer Drug For Rare Type Of Neuroendocrine Tumors

Merck (NYSE:MRK) Showcases Broad Cancer Research Portfolio At ASCO Annual Meeting

MRK

Simply Wall St.

17 days ago

Merck (NYSE:MRK) Showcases Broad Cancer Research Portfolio At ASCO Annual Meeting

MRK

MT Newswires

18 days ago

Citigroup Downgrades Merck & Co. to Neutral From Buy, Adjusts Price Target to $84 From $115

Is Merck & Co. (MRK) the Best Pharma Stock to Invest in Amid the Domestic Manufacturing Boom?

MRK

Insider Monkey

18 days ago

Is Merck & Co. (MRK) the Best Pharma Stock to Invest in Amid the Domestic Manufacturing Boom?

Research on Novel Treatment Approaches and Scientific Advances From Merck’s Broad and Differentiated Oncology Portfolio and Pipeline to be Presented at ASCO 2025

MRK

Business Wire

19 days ago

Research on Novel Treatment Approaches and Scientific Advances From Merck’s Broad and Differentiated Oncology Portfolio and Pipeline to be Presented at ASCO 2025

Trump's drug price order is part request, part threat: Analyst

MRK

Yahoo Finance Video

19 days ago

Trump's drug price order is part request, part threat: Analyst

MRK

Morningstar Research

19 days ago

Analyst Report: Merck & Co., Inc.

How Trump could go about executing order to slash drug prices

MRK

Yahoo Finance Video

19 days ago

How Trump could go about executing order to slash drug prices

Merck & Co., Inc. (MRK): One of the Worst Blue Chip Stocks to Buy

MRK

Insider Monkey

19 days ago

Merck & Co., Inc. (MRK): One of the Worst Blue Chip Stocks to Buy

Drug wars: Wall Street says big questions remain about impact of Trump's new pricing order

MRK

Yahoo Finance

19 days ago

Drug wars: Wall Street says big questions remain about impact of Trump's new pricing order

Mag 7 rally, airline & pharmaceutical stocks: Trending Tickers

MRK

Yahoo Finance Video

20 days ago

Mag 7 rally, airline & pharmaceutical stocks: Trending Tickers

MRK Q1 Earnings Call: Pipeline Expansion, Tariff Pressures, and Portfolio Diversification

MRK

StockStory

20 days ago

MRK Q1 Earnings Call: Pipeline Expansion, Tariff Pressures, and Portfolio Diversification

Is Merck & Co., Inc. (MRK) the Best Income Stock to Invest in Now?

MRK

Insider Monkey

22 days ago

Is Merck & Co., Inc. (MRK) the Best Income Stock to Invest in Now?

Shareholders Will Be Pleased With The Quality of Merck's (NYSE:MRK) Earnings

MRK

Simply Wall St.

23 days ago

Shareholders Will Be Pleased With The Quality of Merck's (NYSE:MRK) Earnings

Merck Animal Health and State of Kansas Announce $895 Million Investment in Manufacturing and Research & Development Facilities in De Soto

MRK

Business Wire

24 days ago

Merck Animal Health and State of Kansas Announce $895 Million Investment in Manufacturing and Research & Development Facilities in De Soto

Is Merck & Co., Inc. (MRK) the Best Dow Stock?

MRK

Insider Monkey

24 days ago

Is Merck & Co., Inc. (MRK) the Best Dow Stock?

Merck (NYSE:MRK) Launches Next-Gen Digital Ecosystem for Growth Disorders with Dawn Health

MRK

Simply Wall St.

24 days ago

Merck (NYSE:MRK) Launches Next-Gen Digital Ecosystem for Growth Disorders with Dawn Health

MRK

Insider Monkey

24 days ago

Merck & Co., Inc. (MRK): A Bull Case Theory

Merck & Co., Inc. (MRK): Among Billionaire Mario Gabelli’s Large-Cap Stock Picks with Huge Upside Potential

MRK

Insider Monkey

25 days ago

Merck & Co., Inc. (MRK): Among Billionaire Mario Gabelli’s Large-Cap Stock Picks with Huge Upside Potential

Merck to Participate in the Bank of America 2025 Global Healthcare Conference

MRK

Business Wire

25 days ago

Merck to Participate in the Bank of America 2025 Global Healthcare Conference

Why A Short Strangle Trade Might Be Best For Volatile Stocks Like Merck

MRK

Investor's Business Daily

25 days ago

Why A Short Strangle Trade Might Be Best For Volatile Stocks Like Merck

Is Merck & Co., Inc. (MRK) The Most Profitable Cheap Stock to Buy Now?

MRK

Insider Monkey

a month ago

Is Merck & Co., Inc. (MRK) The Most Profitable Cheap Stock to Buy Now?

Merck & Co., Inc. (MRK): Jim Cramer Agrees – “Merck’s A Good Company”

MRK

Insider Monkey

a month ago

Merck & Co., Inc. (MRK): Jim Cramer Agrees – “Merck’s A Good Company”

Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know

MRK

Zacks

a month ago

Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know

Arvinas, Entrada cut staff; Merck builds US hub for Keytruda

MRK

BioPharma Dive

a month ago

Arvinas, Entrada cut staff; Merck builds US hub for Keytruda

Top Dividend Stocks To Consider In May 2025

MRK

Simply Wall St.

a month ago

Top Dividend Stocks To Consider In May 2025

Is Merck & Co. Inc. (MRK) the Best Dow Stock for the Next 12 Months?

MRK

Insider Monkey

a month ago

Is Merck & Co. Inc. (MRK) the Best Dow Stock for the Next 12 Months?

Merck & Co., Inc. (MRK): Among Billionaire Cliff Asness’ Stock Picks with Huge Upside Potential

MRK

Insider Monkey

a month ago

Merck & Co., Inc. (MRK): Among Billionaire Cliff Asness’ Stock Picks with Huge Upside Potential

MRK

MT Newswires

a month ago

Guggenheim Adjusts Merck & Co.'s Price Target to $108 From $115

MRK

Argus Research

a month ago

Analyst Report: Merck & Co Inc

MRK

Argus Research

a month ago

Market Digest: GLW, MRK, PG, SYY, XEL, WRB, PYPL, NXPI

Construction begins on MSD’s $1bn biologics centre in Delaware, US

MRK

Pharmaceutical Technology

a month ago

Construction begins on MSD’s $1bn biologics centre in Delaware, US

How To Put $100 In Your Retirement Fund Each Month With Merck Stock

MRK

Benzinga

a month ago

How To Put $100 In Your Retirement Fund Each Month With Merck Stock

Pfizer offers 'longer-term' opportunity amid tariff uncertainty

MRK

Yahoo Finance Video

a month ago

Pfizer offers 'longer-term' opportunity amid tariff uncertainty

Is Merck & Co., Inc. (MRK) the Worst-Performing Blue Chip Stock So Far in 2025?

MRK

Insider Monkey

a month ago

Is Merck & Co., Inc. (MRK) the Worst-Performing Blue Chip Stock So Far in 2025?

Merck Breaks Ground on New $1 Billion Biologics Center of Excellence in Wilmington, Delaware

MRK

Business Wire

a month ago

Merck Breaks Ground on New $1 Billion Biologics Center of Excellence in Wilmington, Delaware

Merck to Spend $1 Billion on New Factory to Make U.S. Supplies of Blockbuster Drug

MRK

The Wall Street Journal

a month ago

Merck to Spend $1 Billion on New Factory to Make U.S. Supplies of Blockbuster Drug

Merck (NYSE:MRK) Presents Promising KEYTRUDA Trial Data at AACR 2025 Meeting

MRK

Simply Wall St.

a month ago

Merck (NYSE:MRK) Presents Promising KEYTRUDA Trial Data at AACR 2025 Meeting

Merck Germany Buys US Cancer Drugmaker SpringWorks Therapeutics For Around $4 Billion

MRK

Benzinga

a month ago

Merck Germany Buys US Cancer Drugmaker SpringWorks Therapeutics For Around $4 Billion

Temu, Tesla prices, Merck KGaA deal: Trending Tickers

MRK

Yahoo Finance Video

a month ago

Temu, Tesla prices, Merck KGaA deal: Trending Tickers

Is Merck & Co., Inc. (MRK) the Most Profitable Blue Chip Stock to Buy Now?

MRK

Insider Monkey

a month ago

Is Merck & Co., Inc. (MRK) the Most Profitable Blue Chip Stock to Buy Now?

MRK

MT Newswires

a month ago

HSBC Adjusts Merck & Co Price Target to $100 From $115, Maintains Buy Rating

Should You Buy, Sell or Hold MRK Stock After Q1 Earnings Beat?

MRK

Zacks

a month ago

Should You Buy, Sell or Hold MRK Stock After Q1 Earnings Beat?

Merck & Co., Inc. (MRK): Among Billionaire Ken Fisher’s Healthcare Stock Picks with Massive Upside Potential

MRK

Insider Monkey

a month ago

Merck & Co., Inc. (MRK): Among Billionaire Ken Fisher’s Healthcare Stock Picks with Massive Upside Potential

KEYTRUDA® (pembrolizumab) as Perioperative Treatment With Standard of Care (SOC) Adjuvant Therapy Significantly Improved Event-Free Survival Compared to SOC Alone in Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

MRK

Business Wire

a month ago

KEYTRUDA® (pembrolizumab) as Perioperative Treatment With Standard of Care (SOC) Adjuvant Therapy Significantly Improved Event-Free Survival Compared to SOC Alone in Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

Wall Street’s New Tariff Safe Haven: High-Tax Biotech Stocks

MRK

The Wall Street Journal

a month ago

Wall Street’s New Tariff Safe Haven: High-Tax Biotech Stocks

Akeso survival data for ivonescimab misses expectations, STAT says

MRK

TipRanks

a month ago

Akeso survival data for ivonescimab misses expectations, STAT says

Merck First Quarter 2025 Earnings: Beats Expectations

MRK

Simply Wall St.

a month ago

Merck First Quarter 2025 Earnings: Beats Expectations

MRK

MT Newswires

a month ago

Goldman Sachs Adjusts Merck Price Target to $99 From $103, Maintains Buy Rating

MRK

Zacks

a month ago

Company News for Apr 25, 2025

Halozyme sues Merck; FDA blames cuts for Vanda delay

MRK

BioPharma Dive

a month ago

Halozyme sues Merck; FDA blames cuts for Vanda delay

MRK

Thomson Reuters StreetEvents

a month ago

Q1 2025 Merck & Co Inc Earnings Call

Stocks to Watch Recap: Alphabet, Intel, P&G, Merck

MRK

The Wall Street Journal

a month ago

Stocks to Watch Recap: Alphabet, Intel, P&G, Merck

Merck Stock Reverses, Though Gardasil 'Woes' Continue In China, Japan

MRK

Investor's Business Daily

a month ago

Merck Stock Reverses, Though Gardasil 'Woes' Continue In China, Japan

Merck Q1 Earnings & Sales Beat Estimates, '25 EPS Outlook Cut

MRK

Zacks

a month ago

Merck Q1 Earnings & Sales Beat Estimates, '25 EPS Outlook Cut

Merck (NYSE:MRK) Faces Patent Lawsuit As Earnings Grow US$317 Million In Q1

MRK

Simply Wall St.

a month ago

Merck (NYSE:MRK) Faces Patent Lawsuit As Earnings Grow US$317 Million In Q1

MRK

Morningstar Research

a month ago

Analyst Report: Merck & Co., Inc.

Merck warns of big tariff hit, Hasbro soars, Comcast sinks

MRK

Yahoo Finance Video

a month ago

Merck warns of big tariff hit, Hasbro soars, Comcast sinks

Merck Cuts 2025 Outlook on Tariffs, Charges

MRK

The Wall Street Journal

a month ago

Merck Cuts 2025 Outlook on Tariffs, Charges

Merck, Nokia, Texas Instruments: Trending Tickers

MRK

Yahoo Finance Video

a month ago

Merck, Nokia, Texas Instruments: Trending Tickers

Merck’s (NYSE:MRK) Q1 Sales Beat Estimates

MRK

StockStory

a month ago

Merck’s (NYSE:MRK) Q1 Sales Beat Estimates

MRK

Associated Press Finance

a month ago

Merck: Q1 Earnings Snapshot

Gardasil Sales Decline — Again. Can Dow Jones Stock Merck Take The Hit?

MRK

Investor's Business Daily

a month ago

Gardasil Sales Decline — Again. Can Dow Jones Stock Merck Take The Hit?

Merck Announces First-Quarter 2025 Financial Results

MRK

Business Wire

a month ago

Merck Announces First-Quarter 2025 Financial Results

Alphabet earnings, Fed comments, Nintendo Switch 2: What to Watch

MRK

Yahoo Finance Video

a month ago

Alphabet earnings, Fed comments, Nintendo Switch 2: What to Watch

BioNTech Surges On Summit's Coattails. But Can They Take On Merck?

MRK

Investor's Business Daily

a month ago

BioNTech Surges On Summit's Coattails. But Can They Take On Merck?

Why vaccine makers aren't worried about Trump administration cuts

MRK

Yahoo Finance

a month ago

Why vaccine makers aren't worried about Trump administration cuts

Merck (MRK) Reports Q1: Everything You Need To Know Ahead Of Earnings

MRK

StockStory

a month ago

Merck (MRK) Reports Q1: Everything You Need To Know Ahead Of Earnings

Merck & Co., Inc. (MRK): Among Prem Watsa’s Stock Picks With Highest Potential

MRK

Insider Monkey

a month ago

Latest Merck & Company Inc. (new) (MRK) News on June 1, 2025

Share on Social Networks: